Those authors also evaluated blood microbiota composition according to tumor response and clinical benefit with anti-PD-L1, finding that Gemmatimonadaceae DNA in blood was associated with low response, tumor progression, and worse OS in patients with early antibiotic use. The gene discussed is CD274; the disease is neoplasm.